Liontrust Investment Partners LLP Buys New Shares in Doximity, Inc. $DOCS

Key Points

• Liontrust Investment Partners LLP acquired a new stake in Doximity, purchasing 21,092 shares valued at approximately $1.2 million in the first quarter.
• Brokerage firms have varied opinions on Doximity, with ratings ranging from "in-line" to "outperform," and target prices between $50.00 and $80.00.
• Doximity recently reported earnings of $0.36 per share, exceeding estimates, with a year-over-year revenue growth of 15.2%.

Liontrust Investment Partners LLP acquired a new position in Doximity, Inc. (NASDAQ:DOCS - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 21,092 shares of the company's stock, valued at approximately $1,224,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. VSM Wealth Advisory LLC purchased a new position in shares of Doximity in the 1st quarter valued at approximately $29,000. Allworth Financial LP lifted its stake in shares of Doximity by 104.0% in the 1st quarter. Allworth Financial LP now owns 563 shares of the company's stock valued at $32,000 after purchasing an additional 287 shares during the period. National Bank of Canada FI purchased a new position in shares of Doximity in the 1st quarter valued at approximately $33,000. Spire Wealth Management lifted its stake in shares of Doximity by 73.2% in the 1st quarter. Spire Wealth Management now owns 615 shares of the company's stock valued at $36,000 after purchasing an additional 260 shares during the period. Finally, Kapitalo Investimentos Ltda purchased a new position in shares of Doximity in the 4th quarter valued at approximately $50,000. Hedge funds and other institutional investors own 87.19% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on DOCS. Evercore ISI upgraded Doximity from an "in-line" rating to an "outperform" rating and raised their target price for the company from $50.00 to $70.00 in a research note on Wednesday, July 9th. William Blair reiterated an "outperform" rating on shares of Doximity in a research note on Friday, May 16th. Canaccord Genuity Group lifted their price objective on Doximity from $50.00 to $59.00 and gave the company a "hold" rating in a research note on Friday, August 8th. Bank of America lifted their price objective on Doximity from $55.00 to $62.00 and gave the company a "neutral" rating in a research note on Wednesday, June 25th. Finally, Mizuho lowered their price objective on Doximity from $65.00 to $60.00 and set a "neutral" rating for the company in a research note on Friday, May 16th. Two analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and ten have given a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $66.21.

Doximity Stock Down 3.6%

Shares of Doximity stock traded down $2.3550 on Tuesday, reaching $63.5750. The company's stock had a trading volume of 1,165,300 shares, compared to its average volume of 2,338,769. The company has a market capitalization of $11.91 billion, a price-to-earnings ratio of 63.58, a P/E/G ratio of 4.10 and a beta of 1.36. The firm's fifty day simple moving average is $60.18 and its two-hundred day simple moving average is $60.32. Doximity, Inc. has a 52 week low of $35.32 and a 52 week high of $85.21.

Doximity (NASDAQ:DOCS - Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported $0.36 EPS for the quarter, topping analysts' consensus estimates of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.The company's quarterly revenue was up 15.2% compared to the same quarter last year. During the same period last year, the business posted $0.28 earnings per share. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. As a group, research analysts predict that Doximity, Inc. will post 0.99 EPS for the current year.

Insider Buying and Selling

In related news, Director Regina M. Benjamin sold 5,000 shares of Doximity stock in a transaction on Friday, August 8th. The stock was sold at an average price of $63.00, for a total value of $315,000.00. Following the completion of the sale, the director owned 16,618 shares of the company's stock, valued at $1,046,934. The trade was a 23.13% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Kira Scherer Wampler sold 2,000 shares of Doximity stock in a transaction on Friday, August 1st. The stock was sold at an average price of $57.09, for a total value of $114,180.00. Following the completion of the sale, the director directly owned 16,618 shares of the company's stock, valued at $948,721.62. The trade was a 10.74% decrease in their position. The disclosure for this sale can be found here. Insiders sold 36,000 shares of company stock valued at $2,140,940 over the last 90 days. Company insiders own 31.30% of the company's stock.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.